Rhythm Pharmaceuticals
(NASDAQ) RYTM
Rhythm Pharmaceuticals Financials at a Glance
Market Cap
$6.95B
Revenue (TTM)
$217.17M
Net Income (TTM)
-$202.68M
EPS (TTM)
-$3.14
P/E Ratio
-32.31
Dividend
$0.00
Beta (Volatility)
1.21 (Average)
Dividend
$0.00
Beta (Volatility)
1.21 (Average)
Price
$106.72
Volume
46,781
Open
$100.80
Price
$106.72
Volume
46,781
Open
$100.80
Previous Close
$106.72
Daily Range
$100.80 - $106.95
52-Week Range
$60.80 - $122.20
Estimated Earnings Date
Aug 4, 2026
Dividend
$0.00
Beta (Volatility)
1.21 (Average)
Price
$106.72
Volume
46,781
Open
$100.80
Previous Close
$106.72
Daily Range
$100.80 - $106.95
52-Week Range
$60.80 - $122.20
Estimated Earnings Date
Aug 4, 2026
RYTM News
RYTM: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Rhythm Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
414
CEO
David P. Meeker, MD
Website
www.rhythmtx.comHeadquarters
Boston, MA 02116, US
RYTM Financials
Key Financial Metrics (TTM)
Gross Margin
89.41%
Operating Margin
-90.89%
Net Income Margin
-93.33%
Return on Equity
-203.25%
Return on Capital
-49.80%
Return on Assets
-45.82%
Earnings Yield
-3.10%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$6.95B
Shares Outstanding
68.59M
Volume
46.78K
Avg. Volume
793.89K
Financials (TTM)
Gross Profit
$194.16M
Operating Income
-$197.37M
EBITDA
-$180.75M
Operating Cash Flow
-$119.51M
Capital Expenditure
-$953.00K
Free Cash Flow
-$120.46M
Cash & ST Invst.
$340.63M
Total Debt
$227.02M
Rhythm Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$60.11M
+83.8%
Gross Profit
$52.96M
+82.3%
Gross Margin
88.09%
N/A
Market Cap
$6.95B
N/A
Market Cap/Employee
$24.57M
N/A
Employees
283
N/A
Net Income
-$55.64M
-12.4%
EBITDA
-$50.26M
-15.2%
Quarterly Fundamentals
Total Cash
$340.63M
+8.3%
Total Debt
$227.02M
+5487.4%
Accounts Receivable
$34.19M
+91.8%
Inventory
$28.65M
+48.3%
Long Term Debt
$216.21M
+5532.0%
Short Term Debt
$10.81M
+4724.1%
Return on Assets
-45.82%
N/A
Return on Invested Capital
-58.20%
N/A
Free Cash Flow
-$44.19M
-9.5%
Operating Cash Flow
-$44.19M
-9.5%